Uveitis Drugs Market by Treatment Type (Analgesics, Antibiotics, Antifungal), Disease Type (Anterior Uveitis, Intermediate Uveitis, Panuveitis), Cause, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

The Global Uveitis Drugs Market size was estimated at USD 671.23 million in 2022, USD 724.65 million in 2023, growing at a CAGR of 8.41% to reach USD 1,281.23 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Uveitis Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Uveitis Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment Type, the market is studied across Analgesics, Antibiotics, Antifungal, Antivirals, Corticosteroids, Cycloplegic Agents, Immunosuppressant, and Monoclonal Antibodies. The Corticosteroids is projected to witness significant market share during forecast period.
Based on Disease Type, the market is studied across Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Posterior Uveitis. The Intermediate Uveitis is projected to witness significant market share during forecast period.
Based on Cause, the market is studied across Infectious and Noninfectious. The Infectious is projected to witness significant market share during forecast period.
Based on Distribution Channel, the market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Online Pharmacies is projected to witness significant market share during forecast period.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Uveitis Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

Market Penetration: Provides comprehensive information on the market offered by the key players
Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

What is the market size and forecast of the Global Uveitis Drugs Market?
What are the inhibiting factors and impact of COVID-19 shaping the Global Uveitis Drugs Market during the forecast period?
Which are the products/segments/applications/areas to invest in over the forecast period in the Global Uveitis Drugs Market?
What is the competitive strategic window for opportunities in the Global Uveitis Drugs Market?
What are the technology trends and regulatory frameworks in the Global Uveitis Drugs Market?
What is the market share of the leading vendors in the Global Uveitis Drugs Market?
What modes and strategic moves are considered suitable for entering the Global Uveitis Drugs Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Uveitis Drugs Market, by Treatment Type, 2022 vs 2030
4.3. Uveitis Drugs Market, by Disease Type, 2022 vs 2030
4.4. Uveitis Drugs Market, by Cause, 2022 vs 2030
4.5. Uveitis Drugs Market, by Distribution Channel, 2022 vs 2030
4.6. Uveitis Drugs Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of uveitis
5.1.1.2. Surge in R&D activities in the field of ophthalmology
5.1.1.3. Growing infectious diseases contribute to the prevalence of uveitis
5.1.2. Restraints
5.1.2.1. Limited awareness among population
5.1.3. Opportunities
5.1.3.1. Increasing number of clinical trials for eye inflammation treatment
5.1.3.2. Positive prospect for corticosteroid implants
5.1.4. Challenges
5.1.4.1. Drug availability issues
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Uveitis Drugs Market, by Treatment Type

6.1. Introduction
6.2. Analgesics
6.3. Antibiotics
6.4. Antifungal
6.5. Antivirals
6.6. Corticosteroids
6.7. Cycloplegic Agents
6.8. Immunosuppressant
6.9. Monoclonal Antibodies

7. Uveitis Drugs Market, by Disease Type

7.1. Introduction
7.2. Anterior Uveitis
7.3. Intermediate Uveitis
7.4. Panuveitis
7.5. Posterior Uveitis

8. Uveitis Drugs Market, by Cause

8.1. Introduction
8.2. Infectious
8.3. Noninfectious

9. Uveitis Drugs Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Uveitis Drugs Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Uveitis Drugs Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Uveitis Drugs Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AbbVie Inc.
14.1.3. Bausch & Lomb Pvt. Ltd.
14.1.4. Cadila Healthcare Ltd.
14.1.5. Emcure Pharmaceuticals Ltd
14.1.6. Eyepoint Pharmaceuticals Inc.
14.1.7. Glenmark Pharmaceuticals Ltd.
14.1.8. Hetero Drugs Ltd.
14.1.9. Johnson & Johnson Services, Inc.
14.1.10. Novartis AG
14.1.11. Pfizer Ltd.
14.1.12. Sun Pharmaceutical Industries Ltd.
14.1.13. Sunways India Pvt. Ltd.
14.1.14. Syntho Pharmaceuticals Pvt. Ltd.
14.1.15. Torrent Pharmaceuticals Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. UVEITIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. UVEITIS DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. UVEITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
FIGURE 5. UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
FIGURE 6. UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2022 VS 2030 (%)
FIGURE 7. UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 8. UVEITIS DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. UVEITIS DRUGS MARKET DYNAMICS
FIGURE 10. UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS UVEITIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES UVEITIS DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC UVEITIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UVEITIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. UVEITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. UVEITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. UVEITIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UVEITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 5. UVEITIS DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. UVEITIS DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. UVEITIS DRUGS MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. UVEITIS DRUGS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. UVEITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. UVEITIS DRUGS MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. UVEITIS DRUGS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. UVEITIS DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 14. UVEITIS DRUGS MARKET SIZE, BY ANTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. UVEITIS DRUGS MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. UVEITIS DRUGS MARKET SIZE, BY PANUVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. UVEITIS DRUGS MARKET SIZE, BY POSTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 19. UVEITIS DRUGS MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. UVEITIS DRUGS MARKET SIZE, BY NONINFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. UVEITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. UVEITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. UVEITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS UVEITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. CANADA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 41. CANADA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. MEXICO UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES UVEITIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC UVEITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CHINA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 63. CHINA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 67. INDIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. JAPAN UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. THAILAND UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA UVEITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. DENMARK UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EGYPT UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FINLAND UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. FRANCE UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. GERMANY UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. ITALY UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 136. ITALY UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. NORWAY UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. POLAND UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 152. POLAND UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. QATAR UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 156. QATAR UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SPAIN UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. TURKEY UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM UVEITIS DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM UVEITIS DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM UVEITIS DRUGS MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM UVEITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. UVEITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 194. UVEITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 195. UVEITIS DRUGS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AbbVie Inc.
Bausch & Lomb Pvt. Ltd.
Cadila Healthcare Ltd.
Emcure Pharmaceuticals Ltd
Eyepoint Pharmaceuticals Inc.
Glenmark Pharmaceuticals Ltd.
Hetero Drugs Ltd.
Johnson & Johnson Services, Inc.
Novartis AG
Pfizer Ltd.
Sun Pharmaceutical Industries Ltd.
Sunways India Pvt. Ltd.
Syntho Pharmaceuticals Pvt. Ltd.
Torrent Pharmaceuticals Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 724.65 Million
Forecasted Market Value ( USD ) by 2030	$ 1281.23 Million
Compound Annual Growth Rate	8.4%
Regions Covered	Global
No. of Companies Mentioned	15

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3481EUR$3,545USD£2,904GBP €3868EUR$3,939USD£3,227GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4373EUR$4,454USD£3,649GBP €4859EUR$4,949USD£4,054GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6158EUR$6,272USD£5,138GBP €6843EUR$6,969USD£5,709GBP

Uveitis Drugs Market by Treatment Type (Analgesics, Antibiotics, Antifungal), Disease Type (Anterior Uveitis, Intermediate Uveitis, Panuveitis), Cause, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

Market Segmentation & Coverage:

Market Statistics:

FPNV Positioning Matrix:

Market Share Analysis:

The report provides insights on the following pointers:

The report answers questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Market Segmentation & Coverage:

Market Statistics:

FPNV Positioning Matrix:

Market Share Analysis:

The report provides insights on the following pointers:

The report answers questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Uveitis Treatment Market by Type of Treatment, End-user, Application, Drug Type, Patient Demographics, Route of Administration, Disease Causation, Therapeutic Class, Diagnostic Methods - Global Forecast 2025-2030

Anterior Uveitis Treatment Market by Treatment Type, Distribution Channel - Global Forecast 2025-2030

Anterior Uveitis Treatment Market Size, Share & Trends Analysis Report By Type (Infectious Uveitis), By Therapy (Biologics), By Distribution Channel (Hospital, Retail, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

Uveitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Uveitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)